Table 3.

Proportion of All Patients Receiving a Monitoring Test, Excluding Patients Who Died

Blood PressureTotal CholesterolHbA1c
Cancer TypeHistory of Hypertension 
 % (95% CI)History of Diabetes 
 % (95% CI)History of CAD/MI 
 % (95% CI)History of Diabetes 
 % (95% CI)History of Cerebrovascular Disease 
 % (95% CI)History of Diabetes 
 % (95% CI)
CAD=coronary artery disease; CI=confidence interval; HbA1c= glycated hemoglobin; MI=myocardial infarction.
Breast
    Survivor93.3 (92.5–94.1)94.7 (91.2–97.7)89.0 (85.3–91.9)90.5 (86.3–93.8)76.0 (68.3–82.7)91.3 (87.2–94.4)
    Control94.8 (94.1–95.5)95.8 (92.7–97.9)89.5 (85.9–92.4)92.1 (88.1–95.0)84.2 (77.3–89.7)88.6 (84.1–92.2)
Colorectal
    Survivor93.9 (92.5–95.1)93.5 (87.7–97.2)86.2 (82.2–89.6)84.7 (77.1–90.5)74.7 (65.2–82.8)86.3 (78.9–91.8)
    Control95.3 (94.1–96.4)91.9 (85.7–96.1)90.1 (86.6–93.0)89.5 (82.7–94.3)85.4 (77.1–91.6)88.7 (81.8–93.7)
Prostate
    Survivor92.5 (90.8–93.9)90.2 (83.6–94.9)88.7 (85.3–91.5)86.9 (79.7–92.4)77.0(66.8–85.4)83.7 (76.0–89.8)
    Control92.1 (90.3–93.6)93.5 (87.6–97.2)89.6 (86.3–92.3)86.9 (79.7–92.4)79.3 (69.3–87.3)86.9 (79.7–92.4)